Hepatitis C Positive Organ Donation in Heart Transplantation

Area of Science:

• Cardiology
• Transplantation Medicine
• Infectious Diseases

Background:

• Increasing donor heart shortages necessitate innovative solutions.
• Hepatitis C virus (HCV) positive donors represent an underutilized resource.
• Advancements in HCV treatment offer new possibilities for organ transplantation.

Purpose of the Study:

• To review current outcomes of heart transplantation using HCV positive donors.
• To identify key considerations and remaining questions regarding this strategy.
• To assess the feasibility of expanding the donor pool with HCV positive organs.

Main Methods:

• Review of single-center studies and registry data.
• Analysis of outcomes in patients receiving hearts from HCV positive donors.
• Evaluation of treatment efficacy and patient survival post-transplantation.

Main Results:

• Direct-acting antiviral therapies (DAAT) are effective and well-tolerated in patients with donor-transmitted HCV.
• Short-term survival in recipients of HCV positive donor hearts is comparable to those receiving HCV negative donor hearts.
• Utilization of HCV positive donors can expand the donor pool and reduce waitlist times.

Conclusions:

• Transplanting hearts from HCV positive donors is a viable strategy to address donor shortages.
• DAAT effectively manages post-transplant HCV infection, ensuring comparable short-term outcomes.
• Further research is required to ascertain the long-term outcomes associated with this approach.